Dr. Jakub Tolar Named Dean of the UMN Medical School

Today President Eric Kaler announced Jakub Tolar, MD, PhD as the next dean of the University of Minnesota Medical School pending Board of Regents approval.

Dr. Tolar is an internationally recognized leader in regenerative medicine who has been with the University of Minnesota for 25 years. A dedicated educator, Jakub's expertise spans the fields of basic science and clinical medicine, and he is revered for his dedication to improving human health. 

In addition to his role as dean, President Kaler has appointed Dr. Tolar as interim vice president for the Health Sciences while the University determines an ideal structure for the continued success of our health sciences.

"I am confident that Jakub will continue our positive momentum through his energetic commitment to advancing discovery, educating the next generation of healthcare leaders, and leading in high-quality clinical care," said Eric Kaler, President of the University of Minnesota.

Dr. Tolar will begin his new roles as dean and interim Vice President of the Health Sciences on Monday, October 23, 2017. Tolar succeeds Dean/VP Brooks Jackson who has accepted a position as Vice President for Medical Affairs and Dean of Medicine at the University of Iowa.

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”